The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gasche, C.
Right arrow Articles by Gangl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gasche, C.
Right arrow Articles by Gangl, A.
The Journal of Immunology, 2003, 170: 5578-5582.
Copyright © 2003 by The American Association of Immunologists

Novel Variants of the IL-10 Receptor 1 Affect Inhibition of Monocyte TNF-{alpha} Production1

Christoph Gasche2,*, Paul Grundtner*, Petra Zwirn*, Walter Reinisch*, Sarah H. Shaw3,{dagger}, Alexander Zdanov{ddagger}, Usha Sarma§, Lynn M. Williams§, Brian M. Foxwell§ and Alfred Gangl*

* Department of Medicine 4, Division of Gastroenterology and Hepatology, University of Vienna, Vienna, Austria; {dagger} DNA Sciences, Inc., Fremont, CA 94555; {ddagger} Macromolecular Crystallography Laboratory, National Cancer Institute, Frederick, MD 21702; and § Imperial College School of Medicine, Kennedy Institute of Rheumatology, London, United Kingdom

IL-10-deficient mice exhibit spontaneous enterocolitis and other symptoms akin to Crohn’s disease, indicating that IL-10 might regulate normal physiology in the gut. However, clinical trials with IL-10 in Crohn’s disease were disappointing, although some patients showed healing of intestinal mucosa. This study searched for genetic polymorphisms within the IL-10 pathway. We decided to screen for mutations of the IL-10R1 cDNA in healthy volunteers and Crohn’s disease patients and identified two novel variants: a serine 138-to-glycine (S138G) and a glycine 330-to-arginine (G330R) substitution. The allelic frequency in a European cohort was relatively high (16% for the S138G and 33% for the G330R), and S138G was in strong linkage disequilibrium with G330R. A similar allele frequency was found in a group of Crohn’s patients. In IL-10R1 G330R-expressing monocytes, the inhibitory effect of IL-10 on TNF-{alpha} production was diminished, indicating that this variant may be a loss-of-function allele. No such difference was observed between haplotypes 4 (G330R only) and 7 (S138G and G330R). In addition, these IL-10R1 variants had no influence on the IL-10R1 expression density. Structural analysis of the S138G variant revealed that the substitution of S138G may interfere with binding of IL-10 to IL-10R1.




This article has been cited by other articles:


Home page
Int ImmunolHome page
N. Tamassia, F. Calzetti, N. Menestrina, M. Rossato, F. Bazzoni, L. Gottin, and M. A. Cassatella
Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10
Int. Immunol., April 1, 2008; 20(4): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J-Q. He, K. Shumansky, X. Zhang, J. E. Connett, N. R. Anthonisen, and A. J. Sandford
Polymorphisms of interleukin-10 and its receptor and lung function in COPD
Eur. Respir. J., June 1, 2007; 29(6): 1120 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
E V Fowler, R Eri, G Hume, S Johnstone, N Pandeya, D Lincoln, D Templeton, and G L Radford-Smith
TNF{alpha} and IL10 SNPs act together to predict disease behaviour in Crohn's disease
J. Med. Genet., June 1, 2005; 42(6): 523 - 528.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.